English
Regional settings| Spread | 0.05 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 5.77 |
| Open | 5.75 |
| 1-Year Change | -30.39% |
| Day's Range | 5.75 - 5.8 |
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
BRIEF: For the six months ended 30 November 2021, AngioDynamics, Inc. revenues increased 9% to $155.3M. Net loss increased 80% to $15.3M. Revenues reflect United States segment increase of 13% to $129.8M. Higher net loss reflects Sales and marketing - Balancing value increase of 27% to $48M (expense), Legal increase from $2M to $4.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.22 to -$0.39.
Common Stock $.01 Par, 08/11, 45M auth., 24,975,757 issd. Insiders & Strategic Owns 1.71%. IPO5/27/04,1.95M shares @ $11 by RBC Capital Markets. 01/07, Co. acquired RITA Medical Systems, Inc. @ 0.1722 shares (23,340,205 shares issd.).
